Q2 2026 Holdings
Filed 2026-08-14 | 22 holdings | $217.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $26.9M | 219,333 | 12.4% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $25.9M | 3,727,348 | 11.9% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $25.1M | 1,775,759 | 11.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $16.8M | 312,496 | 7.7% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $16.4M | 889,164 | 7.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $14.6M | 131,758 | 6.7% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $13.7M | 89,909 | 6.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.1M | 183,225 | 5.1% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $10.8M | 426,736 | 5.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $7.6M | 706,124 | 3.5% |
| Inventiva SA(IVA) | ADS | 46124U107 | $6.8M | 1,787,984 | 3.1% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $6.7M | 372,856 | 3.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.2M | 107,223 | 2.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $5.1M | 131,075 | 2.3% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $5.0M | 1,306,800 | 2.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $3.9M | 52,655 | 1.8% |
| Pharvaris N V(PHVS) | COM | N69605108 | $3.7M | 108,055 | 1.7% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $3.5M | 183,362 | 1.6% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $2.5M | 100,732 | 1.1% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $2.2M | 68,249 | 1.0% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $1.6M | 119,063 | 0.7% |
| Adicet BIO Inc(ACET) | COM NEW | 007002207 | $1.4M | 157,827 | 0.6% |